4.7 Review

Implementation and relevance of FAIR data principles in biopharmaceutical R&D

Journal

DRUG DISCOVERY TODAY
Volume 24, Issue 4, Pages 933-938

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.drudis.2019.01.008

Keywords

-

Ask authors/readers for more resources

Biopharmaceutical industry R&D, and indeed other life sciences R&D such as biomedical, environmental, agricultural and food production, is becoming increasingly data-driven and can significantly improve its efficiency and effectiveness by implementing the FAIR (findable, accessible, interoperable, reusable) guiding principles for scientific data management and stewardship. By so doing, the plethora of new and powerful analytical tools such as artificial intelligence and machine learning will be able, automatically and at scale, to access the data from which they learn, and on which they thrive. FAIR is a fundamental enabler for digital transformation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available